Zacks
Universal Health's Q4 Earnings Miss on Softer Volumes & Rising Costs
➖
AI Sentiment
Neutral
5/10
- Home
- HCA
as of 02-27-2026 3:49pm EST
$532.13
+$6.25
+1.19%
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
| Founded: | 1968 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 119.9B | IPO Year: | 2009 |
| Target Price: | $524.26 | AVG Volume (30 days): | 983.8K |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | Dividend Payout Frequency: | monthly | |
| EPS: | 28.33 | EPS Growth: | 28.77 |
| 52 Week Low/High: | $307.40 - $552.90 | Next Earning Date: | 04-28-2026 |
| Revenue: | $75,600,000,000 | Revenue Growth: | 7.08% |
| Revenue Growth (this year): | 5.1% | Revenue Growth (next year): | 4.94% |
| P/E Ratio: | 18.60 | Index: | |
| Free Cash Flow: | 7.7B | FCF Growth: | +36.41% |
AI-Powered HCA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 76.13%
76.13%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of HCA Healthcare Inc. (HCA)
McAlevey Michael R
Sell
EVP & Chief Legal & Admin Off.
HCA Feb 18, 2026
Avg Cost/Share
$533.37
Shares
1,694
Total Value
$903,536.74
Owned After
8,853
SEC Form 4
Wyatt Christopher F.
Sell
SVP & Controller
HCA Feb 11, 2026
Avg Cost/Share
$505.00
Shares
4,000
Total Value
$2,020,000.00
Owned After
44,379
SEC Form 4
Berres Jennifer
Sell
SVP & Chief Human Res. Officer
HCA Feb 11, 2026
Avg Cost/Share
$514.58
Shares
8,020
Total Value
$4,126,950.05
Owned After
16,003
HAZEN SAMUEL N
Sell
CEO
HCA Feb 3, 2026
Avg Cost/Share
$499.99
Shares
42,877
Total Value
$21,483,274.82
Owned After
60,437
Cuffe Michael S.
Sell
EVP and Chief Clinical Officer
HCA Feb 3, 2026
Avg Cost/Share
$498.09
Shares
1,500
Total Value
$747,135.15
Owned After
30,002.902
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| McAlevey Michael R | HCA | EVP & Chief Legal & Admin Off. | Feb 18, 2026 | Sell | $533.37 | 1,694 | $903,536.74 | 8,853 | |
| Wyatt Christopher F. | HCA | SVP & Controller | Feb 11, 2026 | Sell | $505.00 | 4,000 | $2,020,000.00 | 44,379 | |
| Berres Jennifer | HCA | SVP & Chief Human Res. Officer | Feb 11, 2026 | Sell | $514.58 | 8,020 | $4,126,950.05 | 16,003 | |
| HAZEN SAMUEL N | HCA | CEO | Feb 3, 2026 | Sell | $499.99 | 42,877 | $21,483,274.82 | 60,437 | |
| Cuffe Michael S. | HCA | EVP and Chief Clinical Officer | Feb 3, 2026 | Sell | $498.09 | 1,500 | $747,135.15 | 30,002.902 |
Latest HCA Healthcare Inc. News
HCA Breaking Stock News: Dive into HCA Ticker-Specific Updates for Smart Investing
Zacks
Danaher (DHR) Down 4.7% Since Last Earnings Report: Can It Rebound?
➖
AI Sentiment
Neutral
4/10
Motley Fool
This Fund Sold $38 Million in Appian Stock Last Quarter. Shares Have Fallen Over 25% This Year
📉
AI Sentiment
Negative
3/10
Barchart
How Is HCA Healthcare's Stock Performance Compared to Other Healthcare Providers Stocks?
📈
AI Sentiment
Highly Positive
8/10
Zacks
Teladoc Tops Q4 Earnings Estimates on International Growth & Lower Costs
➖
AI Sentiment
Neutral
4/10
Business Wire
HCA Healthcare Named a World’s Most Admired Company by Fortune for the 12th Consecutive Year
📈
AI Sentiment
Highly Positive
9/10
Compare HCA vs Leading Stocks
See how HCA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HCA HCA Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.